Biorestorative Therapies Inc (BRTX) Return on Investment ROI from the first quarter of 2026 to first quarter of 2025 and for the year 2026, average high and low, overall ranking from Mar 31 2026 to Mar 31 2025 - CSIMarket
CSIMarket
 


Biorestorative Therapies Inc   (NASDAQ: BRTX)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Biorestorative Therapies Inc's ROI from its first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Biorestorative Therapies Inc's ROI in the first quarter of 2026?
Biorestorative Therapies Inc recorded a cumulative net loss of $-11 million during 12 months ending in the first quarter of 2026, resulting in a negative return on investment (ROI) of -423.84%.

Within the Healthcare sector 837 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Mar 31 2026 quarter, so far to 4371, from total ROI ranking in the fourth quarter of 2025 at 5058.

Definition and Formula of Return on Investment



Return On Investment (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Investment Change TTM -70.7 % -68.73 % -51.7 % -35.61 % -6.26 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 3 0 2 5 6
Return On Investment (TTM) -423.84 % -415.71 % -231.65 % -144.6 % -135.84 %
BRTX's Overall Ranking # 4371 # 5058 # 4382 # 4334 # 4376
Seq. Investment Change TTM -23.86 % -37.36 % -26.24 % -16.72 % -18.73 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -11 -14 -13 -11 -12




Return On Investment BRTX's Ranking
Within: No.
Industry # 40
Sector # 838
Overall # 4371

Return On Investment Statistics
High Average Low
-37.34 %
-344.53 %
-1183.9 %
(Jun 30 2024)   (Jun 30 2021)







Financial Statements
Biorestorative Therapies Inc's I. Quarter Investments $ 3 Millions BRTX's Balance sheet
Biorestorative Therapies Inc's I. Quarter Income $ -2 Millions Quarterly BRTX's Income Statement
BRTX's Income by Division See BRTX's Income by Division


BRTX Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 0 9 10 16 22
Y / Y Investment Growth -95.82 % -14.72 % -36.81 % -27.34 % 559.79 %
Net Income in Millions -14 -9 -10 -18 -44
Y / Y Net Income Growth - - - - -
Annual Return On Investment -3992.21 % -105.25 % -104.13 % -116.82 % -203.34 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BRTX's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BRTX's Competitors
Subscribers only: Roi for Biorestorative Therapies Inc's Suppliers
Subscribers only: Return On Investment for BRTX's Customers

Other Ratios
BRTX's Roa BRTX's Inventory Turnover Ratio BRTX's Growth Rates BRTX's Dividend Statistics
BRTX's Profitability Ratios BRTX's Asset Turnover Ratio BRTX's Dividend Growth
BRTX's Roe BRTX's Valuation Ratios BRTX's Financial Strength Ratios BRTX's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector ROI


Date modified: 2026-09-08T17:44:21+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.